PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT: RESULTS FROM THE HOVON‐109 STUDY. (12th June 2019) - van der Straten, L.; Hosnijeh, F.; van der Straten, L.; Kater, A.P.; van Oers, M.H.; Posthuma, W.F.; Chamuleau, M.E.; Nijland, M.; Hoogendoorn, M.; De Croon, F.; Wittebol, S.; Kerst, J.; et al.